Detalles de la búsqueda
1.
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL).
Lancet
; 401(10370): 25-37, 2023 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36493791
2.
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE).
Lancet
; 401(10370): 38-48, 2023 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36495881
3.
Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE.
Rheumatology (Oxford)
; 62(2): 617-628, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35789257
4.
Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial.
Lancet
; 395(10222): 427-440, 2020 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32035552
5.
Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study.
Ann Rheum Dis
; 77(6): 914-921, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29514803
6.
Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study.
Arthritis Rheumatol
; 74(12): 1959-1970, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35829656
7.
Successful administration of BI 695501, an adalimumab biosimilar, using an autoinjector (AI): results from a Phase II open-label clinical study (VOLTAIRE®-RL).
Expert Opin Drug Deliv
; 15(6): 545-548, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29764238
8.
Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants.
Hum Vaccin Immunother
; 13(3): 588-598, 2017 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27768515
9.
Safety and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTPa-IPV/Hib) vaccine in healthy Vietnamese toddlers: An open-label, phase III study.
Hum Vaccin Immunother
; 12(3): 655-7, 2016 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26337197
10.
Bioequivalence, safety and immunogenicity of BI 695501, an adalimumab biosimilar candidate, compared with the reference biologic in a randomized, double-blind, active comparator phase I clinical study (VOLTAIRE®-PK) in healthy subjects.
Expert Opin Investig Drugs
; 25(12): 1361-1370, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27813422
11.
Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib vaccine in Canadian Aboriginal and non-Aboriginal infants.
Vaccine
; 33(16): 1897-900, 2015 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25701314
12.
Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Hum Vaccin Immunother
; 10(10): 2795-8, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25483640
13.
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice.
J Clin Invest
; 120(4): 1111-24, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20234093
14.
In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells.
Cancer Res
; 68(23): 9892-9, 2008 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19047170
15.
The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccines.
Cancer Immunol Immunother
; 56(1): 70-80, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16555057
16.
Immunotherapeutic potential of DISC-HSV and OX40L in cancer.
Cancer Immunol Immunother
; 55(1): 104-11, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16001161
Resultados
1 -
16
de 16
1
Próxima >
>>